Deferred Tax Assets, Net of Valuation Allowance in USD of Twist Bioscience Corp from Q3 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Twist Bioscience Corp quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q3 2018 to Q3 2025.
  • Twist Bioscience Corp Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Sep 2025 was $15.4M, a 15.5% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Twist Bioscience Corp Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $15.4M -$2.83M -15.5% 30 Sep 2025 10-K 17 Nov 2025
Q3 2024 $18.2M -$13.7M -42.8% 30 Sep 2024 10-K 17 Nov 2025
Q3 2023 $31.9M -$1.69M -5.02% 30 Sep 2023 10-K 18 Nov 2024
Q3 2022 $33.6M +$13.5M +67.6% 30 Sep 2022 10-K 21 Nov 2023
Q3 2021 $20M +$12.4M +162% 30 Sep 2021 10-K/A 05 Jun 2023
Q3 2020 $7.65M +$7.52M +5924% 30 Sep 2020 10-K 23 Nov 2021
Q3 2019 $127K -$56K -30.6% 30 Sep 2019 10-K 27 Nov 2020
Q3 2018 $183K 30 Sep 2018 10-K 13 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.